CD8A and neoplasm: Those inhibitory receptors could combine with corresponding inhibitory ligands of DCs and tumor cells, induce the disability of CD4+ TILs or suppress the cytotoxic reaction of CD8+ TILs, which finally mediated the immune tolerance to the tumor (Figure 1).